Pseudomonas

Molecular Detection of Foodborne Pathogens

Volumn , Issue , 2009, Pages 431-446

  Zaborina, Olga ^a   Alverdy, John ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84856077370     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (191)

1. Alverdy, J.C., Aoys, E. and Moss, G.S. Effect of commercially available chemically defined liquid diets on the intestinal microflora and bacterial translocation from the gut. Jpn J. Parenter. Enteral. Nutr., 14, 1, 1990.
2. Alverdy, J.C., Aoys, E. and Moss, G.S. Total parenteral nutrition promotes bacterial translocation from the gut. Surgery, 104, 185, 1988.
3. Spaeth, G. et al. Food without fiber promotes bacterial translocation from the gut. Surgery, 108, 240; discussion 246, 1990.
4. Yu, P. and Martin, C.M. Increased gut permeability and bacterial translocation in Pseudomonas pneumonia-induced sepsis. Crit. Care Med., 28, 2573, 2000.
5. Ohara, T. and Itoh, K. Significance of Pseudomonas aeruginosa colonization of the gastrointestinal tract. Intern. Med., 42, 1072, 2003.
6. File, T.M., Jr. et al. An outbreak of Pseudomonas aeruginosa ventilator-associated respiratory infections due to contaminated food coloring dye-further evidence of the significance of gastric colonization preceding nosocomial pneumonia. Infect. Control Hosp. Epidemiol., 16, 417, 1995.
7. Swartz, M.N. Human diseases caused by foodborne pathogens of animal origin. Clin. Infect. Dis., 34 (Suppl 3), S111, 2002.
8. Huang, Y.C., Lin, T.Y. and Wang, C.H. Community-acquired Pseudomonas aeruginosa sepsis in previously healthy infants and children: analysis of forty-three episodes. Pediatr. Infect. Dis. J., 21, 1049, 2002.
9. Martin-Ancel, A., Borque, C. and del Castillo, F. Pseudomonas sepsis in children without previous medical problems. Pediatr. Infect. Dis. J., 12, 258, 1993.
10. Ros, S.P. Pseudomonas bacteremia in a previously healthy 2-year-old boy. Clin. Pediatr. (Phila), 28, 336, 1989.
11. Chusid, M.J. and Hillmann, S.M. Community-acquired Pseudomonas sepsis in previously healthy infants. Pediatr. Infect. Dis. J., 6, 681, 1987.
12. Wu, B.Y. et al. Community-acquired Pseudomonas aeruginosa bacteremia and sepsis in previously healthy infants. Acta Paediatr. Taiwan, 40, 233, 1999.
13. Wong, S.N. et al. Pseudomonas septicaemia in apparently healthy children. Acta Paediatr. Scand., 80, 515, 1991.
14. Flick, M.R. and Cluff, L.E. Pseudomonas bacteremia: Review of 108 cases. Am. J. Med. 60, 501, 1976.
15. Dorff, G.J. et al. Pseudomonas septicemia: Illustrated evolution of its skin lesion. Arch. Intern. Med., 128, 591, 1971.
16. Green, S.K. et al. Agricultural plants and soil as a reservoir for Pseudomonas aeruginosa. Appl. Microbiol., 28, 987, 1974.
17. Leitao, J.H., Alvim, T. and Sa-Correia, I. Ribotyping of Pseudomonas aeruginosa isolates from patients and water springs and genome fingerprinting of variants concerning mucoidy. FEMS Immunol. Med. Microbiol., 13, 287, 1996.
18. Pellett, S., Bigley, D.V. and Grimes, D.J. Distribution of Pseudomonas aeruginosa in a riverine ecosystem. Appl. Environ. Microbiol., 45, 328, 1983.
19. Silva, M.E. et al. Characterisation of potential virulence markers in Pseudomonas aeruginosa isolated from drinking water. Antonie Van Leeuwenhoek, 93, 323, 2008.
20. Khan, N.H. et al. Isolation of Pseudomonas aeruginosa from open ocean and comparison with freshwater, clinical, and animal isolates. Microb. Ecol., 53, 173, 2007.
21. Curran, B. et al. Commercial mushrooms and bean sprouts are a source of Pseudomonas aeruginosa. J. Clin. Microbiol., 43, 5830, 2005.
22. Wright, C., Kominos, S.D. and Yee, R.B. Enterobacteriaceae and Pseudomonas aeruginosa recovered from vegetable salads. Appl. Environ. Microbiol., 31, 453, 1976.
23. McKay, L. et al. Antimicrobial testing of selected fluoroquinolones against Pseudomonas aeruginosa isolated from canine otitis. J. Am. Anim. Hosp. Assoc., 43, 307, 2007.
24. Wallmann, J., Schroer, U. and Kaspar, H. Quantitative resistance level (MIC) of bacterial pathogens (Escherichia coli, Pasteurella multocida, Pseudomonas aeruginosa, Salmonella sp., Staphylococcus aureus) isolated from chickens and turkeys: national resistance monitoring by the BVL 2004/2005. Berl. Munch Tierarztl. Wochenschr., 120, 452, 2007.
25. Aoi, Y., Nakata, H. and Kida, H. Isolation of Pseudomonas aeruginosa from Ushubetsu River water in Hokkaido, Japan. Jpn J. Vet. Res., 48, 29, 2000.
26. Morgan, J.A. et al. Comparison of flagellin genes from clinical and environmental Pseudomonas aeruginosa isolates. Appl. Environ. Microbiol., 65, 1175, 1999.
27. Grobe, S., Wingender, J. and Truper, H.G. Characterization of mucoid Pseudomonas aeruginosa strains isolated from technical water systems. J. Appl. Bacteriol., 79, 94, 1995.
28. Foght, J.M. et al. Environmental gasoline-utilizing isolates and clinical isolates of Pseudomonas aeruginosa are taxonomically indistinguishable by chemotaxonomic and molecular techniques. Microbiology, 142, 2333, 1996.
29. Pornsunthorntawee, O. et al. Structural and physicochemical characterization of crude biosurfactant produced by Pseudomonas aeruginosa SP4 isolated from petroleum-contaminated soil. Bioresour. Technol., 99, 1589, 2008.
30. Vives-Florez, M. and Garnica, D. Comparison of virulence between clinical and environmental Pseudomonas aeruginosa isolates. Int. Microbiol., 9, 247, 2006.
31. Macur, R.E. et al. Impacts of 2, 4-D application on soil microbial community structure and on populations associated with 2, 4-D degradation. Microbiol. Res., 162, 37, 2007.
32. Kleinsteuber, S. et al. Population dynamics within a microbial consortium during growth on diesel fuel in saline environments. Appl. Environ. Microbiol., 72, 3531, 2006.
33. Wongsa, P. et al. Isolation and characterization of novel strains of Pseudomonas aeruginosa and Serratia marcescens possessing high efficiency to degrade gasoline, kerosene, diesel oil, and lubricating oil. Curr. Microbiol., 49, 415, 2004.
34. Kumar, M. et al. Enhanced biodegradation of beta- and deltahexachlorocyclohexane in the presence of alpha- and gammaisomers in contaminated soils. Environ. Sci. Technol., 39, 4005, 2005.
35. Deshpande, N.M., Dhakephalkar, P.K. and Kanekar, P.P. Plasmid-mediated dimethoate degradation in Pseudomonas aeruginosa MCMB-427. Lett. Appl. Microbiol., 33, 275, 2001.
36. Brunsbach, F.R. and Reineke, W. Degradation of chlorobenzenes in soil slurry by a specialized organism. Appl. Microbiol. Biotechnol., 42, 415, 1994.
37. Nawaz, M.S. and Chapatwala, K.D. Simultaneous degradation of acetonitrile and biphenyl by Pseudomonas aeruginosa. Can. J. Microbiol., 37, 411, 1991.
38. Shirkot, C.K. et al. Effectiveness of Pseudomonas aeruginosa for detoxification of tetramethylthiuram disulfide (TMTD) from contaminated soil. Bull. Environ. Contam. Toxicol., 44, 317, 1990.
39. Golovleva, L.A. et al. [Degradation of polychloroaromatic insecticides by Pseudomonas aeruginosa containing biodegradation plasmids]. Mikrobiologiia. 51, 973, 1982.
40. Becker, R., Buge, H.G. and Win, T. Determination of pentachlorophenol (PCP) in waste wood - method comparison by a collaborative trial. Chemosphere, 47, 1001, 2002.
41. Williams, P.L. Pentachlorophenol, an assessment of the occupational hazard. Am. Ind. Hyg. Assoc. J., 43, 799, 1982.
42. Muller, J.F. et al. Transcriptome analysis reveals that multidrug efflux genes are upregulated to protect Pseudomonas aeruginosa from pentachlorophenol stress. Appl. Environ. Microbiol., 73, 4550, 2007.
43. Nehme, D. and Poole, K. Assembly of the MexAB-OprM multidrug pump of Pseudomonas aeruginosa: component interactions defined by the study of pump mutant suppressors. J. Bacteriol., 189, 6118, 2007.
44. Henrichfreise, B. et al. Resistance mechanisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutation. Antimicrob. Agents Chemother., 51, 4062, 2007.
45. Poole, K. Efflux-mediated multi-resistance in Gram-negative bacteria. Clin. Microbiol. Infect., 10, 12, 2004.
46. Alonso, A., Rojo, F. and Martinez, J.L. Environmental and clinical isolates of Pseudomonas aeruginosa show pathogenic and biodegradative properties irrespective of their origin. Environ. Microbiol., 1, 421, 1999.
47. Dantas, G. et al. Bacteria subsisting on antibiotics. Science, 320, 100, 2008.
48. Al-Qadiri, H.M. et al. Rapid detection and identification of Pseudomonas aeruginosa and Escherichia coli as pure and mixed cultures in bottled drinking water using fourier transform infrared spectroscopy and multivariate analysis. J. Agric. Food Chem., 54, 5749, 2006.
49. Blanc, D.S. et al. Faucets as a reservoir of endemic Pseudomonas aeruginosa colonization/infections in intensive care units. Intensive Care Med., 30, 1964, 2004.
50. Correa, C.M., Tibana, A. and Gontijo Filho, P.P. Vegetables as a source of infection with Pseudomonas aeruginosa in a University and Oncology Hospital of Rio de Janeiro. J. Hosp. Infect., 18, 301, 1991.
51. Almuneef, M.A. et al. Rate, risk factors and outcomes of catheter- related bloodstream infection in a paediatric intensive care unit in Saudi Arabia. J. Hosp. Infect., 62, 207, 2006.
52. Trautmann, M. et al. Common RAPD pattern of Pseudomonas aeruginosa from patients and tap water in a medical intensive care unit. Int. J. Hyg. Environ. Health, 209, 325, 2006.
53. Murthy, S.K. et al. Oropharyngeal and fecal carriage of Pseudomonas aeruginosa in hospital patients. J. Clin. Microbiol., 27, 35, 1989.
54. Blanc, D.S. et al. Frequency and molecular diversity of Pseudomonas aeruginosa upon admission and during hospitalization: a prospective epidemiologic study. Clin. Microbiol. Infect., 4, 242, 1998.
55. Drakulovic, M.B. et al. Initial bacterial colonization in patients admitted to a respiratory intensive care unit: bacteriological pattern and risk factors. Respiration, 68, 58, 2001.
56. Garrouste-Orgeas, M. et al. Oropharyngeal or gastric colonization and nosocomial pneumonia in adult intensive care unit patients. A prospective study based on genomic DNA analysis. Am. J. Respir. Crit. Care Med., 156, 1647, 1997.
57. Bertrand, X. et al. Endemicity, molecular diversity and colonisation routes of Pseudomonas aeruginosa in intensive care units. Intensive Care Med., 27, 1263, 2001.
58. Thuong, M. et al. Epidemiology of Pseudomonas aeruginosa and risk factors for carriage acquisition in an intensive care unit. J. Hosp. Infect., 53, 274, 2003.
59. Lepelletier, D. et al. Role of hospital stay and antibiotic use on Pseudomonas aeruginosa gastrointestinal colonization in hospitalized patients. Eur. J. Clin. Microbiol. Infect. Dis., 25, 600, 2006.
60. Agodi, A. et al. Pseudomonas aeruginosa carriage, colonization, and infection in ICU patients. Intensive Care Med., 33, 1155, 2007.
61. Yetkin, G. et al. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey. Am. J. Infect. Control, 34, 188, 2006.
62. Trautmann, M., Lepper, P.M. and Haller, M. Ecology of Pseudomonas aeruginosa in the intensive care unit and the evolving role of water outlets as a reservoir of the organism. Am. J. Infect. Control, 33, S41, 2005.
63. Grundmann, H. et al. Pseudomonas aeruginosa in a neonatal intensive care unit: reservoirs and ecology of the nosocomial pathogen. J. Infect. Dis., 168, 943, 1993.
64. Berthelot, P. et al. Prospective study of nosocomial colonization and infection due to Pseudomonas aeruginosa in mechanically ventilated patients. Intensive Care Med., 27, 503, 2001.
65. Kominos, S.D. et al. Introduction of Pseudomonas aeruginosa into a hospital via vegetables. Appl. Microbiol., 24, 567, 1972.
66. Arias, M.L., Monge, R. and Chavez, C. Microbiological contamination of enteral feeding solutions used in Costa Rican hospitals. Arch. Latinoam Nutr., 53, 277, 2003.
67. Defez, C. et al. Risk factors for multidrug-resistant Pseudomonas aeruginosa nosocomial infection. J. Hosp. Infect., 57, 209, 2004.
68. Harris, A. et al. Epidemiology and clinical outcomes of patients with multi-resistant Pseudomonas aeruginosa. Clin. Infect. Dis., 28, 1128, 1999.
69. Ziha-Zarifi, I. et al. In vivo emergence of multidrug-resistant mutants of Pseudomonas aeruginosa overexpressing the active efflux system MexA-MexB-OprM. Antimicrob. Agents Chemother., 43, 287, 1999.
70. Passos, X.S. et al. Candida colonization in intensive care unit patients’ urine. Mem. Inst. Oswaldo Cruz, 100, 925, 2005.
71. Fanello, S. et al. Predictive value of oral colonization by Candida yeasts for the onset of a nosocomial infection in elderly hospitalized patients. J. Med. Microbiol., 55, 223, 2006.
72. Okesola, A.O., Oni, A.A. and Bakare, R.A. Nosocomial infections: methicillin resistant Staphylococcus auerus in wound infection in Ibadan, Nigeria. Afr. J. Med. Med. Sci., 28, 55, 1999.
73. Mashita, K. et al. [Bacteria isolated from surgical infections and their susceptibilities to antimicrobial agents. Special references to bacteria isolated between April 1997 and March 1998]. Jpn J. Antibiot., 53, 533, 2000.
74. Cunha, B.A. Antimicrobial therapy of multidrug-resistant Streptococcus pneumoniae, vancomycin-resistant enterococci, and methicillin-resistant Staphylococcus aureus. Med. Clin. North Am., 90, 1165, 2006.
75. Carmeli, Y. et al. Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa. Arch. Intern. Med., 159, 1127, 1999.
76. Lautenbach, E. et al. Imipenem resistance among Pseudomonas aeruginosa isolates: risk factors for infection and impact of resistance on clinical and economic outcomes. Infect. Control Hosp. Epidemiol., 27, 893, 2006.
77. Gasink, L.B. et al. Fluoroquinolone-resistant Pseudomonas aeruginosa: assessment of risk factors and clinical impact. Am. J. Med., 119, 526, 2006.
78. Giamarellou, H. and Antoniadou, A. Antipseudomonal antibiotics. Med. Clin. North Am., 85, 19, 2001.
79. Arnoni, M.V., Berezin, E.N. and Martino, M.D. Risk factors for nosocomial bloodstream infection caused by multidrug resistant gram-negative bacilli in pediatrics. Braz. J. Infect. Dis., 11, 267, 2007.
80. Aloush, V. et al. Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact. Antimicrob. Agents Chemother., 50, 43, 2006.
81. Cao, B. et al. [Risk factors and clinical outcomes of nosocomial infections caused by multidrug resistant Pseudomonas aeruginosa]. Zhonghua Jie He He Hu Xi Za Zhi, 27, 31, 2004.
82. Wenzel, R.P. et al. Hospital-acquired infections in intensive care unit patients: an overview with emphasis on epidemics. Infect. Control, 4, 371, 1983.
83. Vincent, J.L. et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European prevalence of infection in intensive care (EPIC) study. EPIC International Advisory Committee. JAMA, 274, 639, 1995.
84. Vincent, J.L. Microbial resistance: lessons from the EPIC study. European prevalence of infection. Intensive Care Med., 26 (Suppl 1), S3, 2000.
85. Aubert, G. et al. Impact of restricting fluoroquinolone prescription on bacterial resistance in an intensive care unit. J. Hosp. Infect., 59, 83, 2005.
86. Ntagiopoulos, P.G. et al. Impact of an antibiotic restriction policy on the antibiotic resistance patterns of Gram-negative microorganisms in an intensive care unit in Greece. Int. J. Antimicrob. Agents, 30, 360, 2007.
87. Rahal, J.J. et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA, 280, 1233, 1998.
88. Kollef, M.H. Is antibiotic cycling the answer to preventing the emergence of bacterial resistance in the intensive care unit? Clin. Infect. Dis., 43 (Suppl 2), S82, 2006.
89. Gerding, D.N. et al. Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital. Antimicrob. Agents Chemother., 35, 1284, 1991.
90. Bennett, K.M. et al. Implementation of antibiotic rotation protocol improves antibiotic susceptibility profile in a surgical intensive care unit. J. Trauma, 63, 307, 2007.
91. Toltzis, P. et al. The effect of antibiotic rotation on colonization with antibiotic-resistant bacilli in a neonatal intensive care unit. Pediatrics, 110, 707, 2002.
92. Moss, W.J. et al. Pilot study of antibiotic cycling in a pediatric intensive care unit. Crit. Care Med., 30, 1877, 2002.
93. Dominguez, E.A. et al. A pilot study of antibiotic cycling in a hematology-oncology unit. Infect. Control Hosp. Epidemiol., 21, S4, 2000.
94. Bergstrom, C.T., Lo, M. and Lipsitch, M. Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals. Proc. Natl. Acad. Sci. USA, 101, 13285, 2004.
95. Tassios, P.T. et al. Multi-resistant Pseudomonas aeruginosa serogroup O: 11 outbreak in an intensive care unit. Clin. Microbiol. Infect., 3, 621, 1997.
96. Obritsch, M.D. et al. Nosocomial infections due to multidrug- resistant Pseudomonas aeruginosa: epidemiology and treatment options. Pharmacotherapy, 25, 1353, 2005.
97. Ratnam, I., Franklin, C. and Spelman, D.W. In vitro activities of ʼnew’ and ‘conventional’ antibiotics against multi-drug resistant Gram negative bacteria from patients in the intensive care unit. Pathology, 39, 586, 2007.
98. Goverman, J. et al. Intravenous colistin for the treatment of multi-drug resistant, gram-negative infection in the pediatric burn population. J. Burn Care Res., 28, 421, 2007.
99. Li, J. et al. Evaluation of colistin as an agent against multiresistant Gram-negative bacteria. Int. J. Antimicrob. Agents, 25, 11, 2005.
100. Giamarellos-Bourboulis, E.J. et al. In vitro interaction of colistin and rifampin on multidrug-resistant Pseudomonas aeruginosa. J. Chemother. 15, 235, 2003.
101. Tascini, C. et al. Clinical and microbiological efficacy of colistin therapy in combination with rifampin and imipenem in multidrug-resistant Pseudomonas aeruginosa diabetic foot infection with osteomyelitis. Int. J. Low Extrem. Wounds, 5, 213, 2006.
102. Tascini, C. et al. Microbiological activity and clinical efficacy of a colistin and rifampin combination in multidrug-resistant Pseudomonas aeruginosa infections. J. Chemother., 16, 282, 2004.
103. Ferrara, A.M. Potentially multidrug-resistant non-fermentative Gram-negative pathogens causing nosocomial pneumonia. Int. J. Antimicrob. Agents, 27, 183, 2006.
104. Zaborina, O. et al. Identification of multi-drug resistant Pseudomonas aeruginosa clinical isolates that are highly disruptive to the intestinal epithelial barrier. Ann. Clin. Microbiol. Antimicrob., 5, 14, 2006.
105. Khakoo, R.A. and Kluge, R.M. Decreased virulence of gentamicin- resistant strains of Pseudomonas aeruginosa in a rat model. J. Lab. Clin. Med., 91, 96, 1978.
106. Keys, T. F. and Washington, J. A., 2nd. Gentamicin-resistant Pseudomonas aeruginosa: Mayo Clinic experience, 1970-1976. Mayo Clin. Proc., 52, 797, 1977.
107. Hostacka, A. et al. Clinical pseudomonas aeruginosa: potential factors of pathogenicity and resistance to antimicrobials. Folia Microbiol. (Praha), 51, 633, 2006.
108. Linares, J.F. et al. Overexpression of the multidrug efflux pumps MexCD-OprJ and MexEF-OprN is associated with a reduction of type III secretion in Pseudomonas aeruginosa. J. Bacteriol. 187, 1384, 2005.
109. Hocquet, D. et al. Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections. Antimicrob. Agents Chemother., 51, 3531, 2007.
110. Ruiz, J. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J. Antimicrob. Chemother., 51, 1109, 2003.
111. Jeannot, K. et al. Induction of the MexXY efflux pump in Pseudomonas aeruginosa is dependent on drug-ribosome interaction. J. Bacteriol., 187, 5341, 2005.
112. Li, X.Z., Poole, K. and Nikaido, H. Contributions of MexAB-OprM and an EmrE homolog to intrinsic resistance of Pseudomonas aeruginosa to aminoglycosides and dyes. Antimicrob. Agents Chemother., 47, 27, 2003.
113. Hauser, A.R. and Sriram, P. Severe Pseudomonas aeruginosa infections: tackling the conundrum of drug resistance. Postgrad. Med., 117, 41, 2005.
114. Pearson, J.P., Van Delden, C. and Iglewski, B.H. Active efflux and diffusion are involved in transport of Pseudomonas aeruginosa cell-to-cell signals. J. Bacteriol. 181, 1203, 1999.
115. Kohler, T. et al. Overexpression of the MexEF-OprN multidrug efflux system affects cell-to-cell signaling in Pseudomonas aeruginosa. J. Bacteriol., 183, 5213, 2001.
116. Stavrinides, J., McCann, H.C. and Guttman, D.S. Hostpathogen interplay and the evolution of bacterial effectors. Cell. Microbiol., 10, 285, 2008.
117. Mota, L.J. and Cornelis, G.R. The bacterial injection kit: type III secretion systems. Ann. Med., 37, 234, 2005.
118. Kubori, T. et al. Molecular characterization and assembly of the needle complex of the Salmonella typhimurium type III protein secretion system. Proc. Natl. Acad. Sci. USA, 97, 10225, 2000.
119. Hueck, C.J. Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol. Mol. Biol. Rev., 62, 379, 1998.
120. Sanchez, P. et al. Fitness of in vitro selected Pseudomonas aeruginosa nalB and nfxB multidrug resistant mutants. J. Antimicrob. Chemother., 50, 657, 2002.
121. Cosson, P. et al. Pseudomonas aeruginosa virulence analyzed in a Dictyostelium discoideum host system. J. Bacteriol. 184, 3027, 2002.
122. Zaborina, O. et al. Structure-function aspects of PstS in multidrug- resistant Pseudomonas aeruginosa. PLoS Pathog., 4, e43, 2008.
123. Alverdy, J. et al. Gut-derived sepsis occurs when the right pathogen with the right virulence genes meets the right host: evidence for in vivo virulence expression in Pseudomonas aeruginosa. Ann. Surg., 232, 480, 2000.
124. Laughlin, R.S. et al. The key role of Pseudomonas aeruginosa PA-I lectin on experimental gut-derived sepsis. Ann. Surg., 232, 133, 2000.
125. Datta, H.K., Malik, M. and Neely, R.D. Hepatic surgeryrelated hypophosphatemia. Clin. Chim. Acta, 380, 13, 2007.
126. Martinez, M. J. et al. Hypophosphatemia in postoperative patients with total parenteral nutrition: influence of nutritional support teams. Nutr Hosp 21, 657-60 (2006).
127. Miller, D.W. and Slovis, C.M. Hypophosphatemia in the emergency department therapeutics. Am. J. Emerg. Med., 18, 457, 2000.
128. Tlaskalova-Hogenova, H. et al. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunol. Lett., 93, 97, 2004.
129. Wu, L. et al. Pseudomonas aeruginosa expresses a lethal virulence determinant, the PA-I lectin/adhesin, in the intestinal tract of a stressed host: the role of epithelia cell contact and molecules of the quorum sensing signaling system. Ann. Surg., 238, 754, 2003.
130. Fang, X.Q., Wang, W.F. and Liu, Y.N. [The role of the quorum sensing system in a rat model of Pseudomonas aeruginosa pulmonary infection and its relationship with the expression of virulence factors]. Zhonghua Jie He He Hu Xi Za Zhi, 29, 458, 2006.
131. Plotkowski, M.C. et al. Early mitochondrial dysfunction, superoxide anion production, and DNA degradation are associated with non-apoptotic death of human airway epithelial cells induced by Pseudomonas aeruginosa exotoxin A. Am. J. Respir. Cell. Mol. Biol., 26, 617, 2002.
132. Schultz, M.J. et al. Impairment of host defence by exotoxin A in Pseudomonas aeruginosa pneumonia in mice. J. Med. Microbiol., 50, 822, 2001.
133. Hirakata, Y. et al. Effect of Pseudomonas aeruginosa exotoxin A on endotoxin-induced tumour necrosis factor production in murine lung. J. Med. Microbiol., 48, 471, 1999.
134. Cummings, J.H. and Macfarlane, G.T. The control and consequences of bacterial fermentation in the human colon. J. Appl. Bacteriol., 70, 443, 1991.
135. Gibson, G.R. and Roberfroid, M.B. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J. Nutr. 125, 1401, 1995.
136. Donskey, C.J. The role of the intestinal tract as a reservoir and source for transmission of nosocomial pathogens. Clin. Infect. Dis., 39, 219, 2004.
137. Edlund, C. and Nord, C.E. Effect on the human normal microflora of oral antibiotics for treatment of urinary tract infections. J. Antimicrob. Chemother., 46 (Suppl. 1), 41; Discussion, 63, 2000.
138. Wu, L.R. et al. Surgical injury and metabolic stress enhance the virulence of the human opportunistic pathogen Pseudomonas aeruginosa. Surg. Infect. (Larchmt), 6, 185, 2005.
139. Patel, N.J. et al. Recognition of intestinal epithelial HIF-1alpha activation by Pseudomonas aeruginosa. Am. J. Physiol. Gastrointest. Liver Physiol. 292, G134, 2007.
140. Alverdy, J., Chi, H.S. and Sheldon, G.F. The effect of parenteral nutrition on gastrointestinal immunity: the importance of enteral stimulation. Ann. Surg. 202, 681, 1985.
141. Alverdy, J., Zaborina, O. and Wu, L. The impact of stress and nutrition on bacterial-host interactions at the intestinal epithelial surface. Curr. Opin. Clin. Nutr. Metab. Care, 8, 205, 2005.
142. Zaborina, O. et al. Dynorphin activates quorum sensing quinolone signaling in Pseudomonas aeruginosa. PLoS Pathog., 3, e35, 2007.
143. Wu, L. et al. Recognition of host immune activation by Pseudomonas aeruginosa. Science, 309, 774, 2005.
144. Kohler, J. E. et al. Components of intestinal epithelial hypoxia activate the virulence circuitry of Pseudomonas. Am. J. Physiol. Gastrointest. Liver Physiol., 288, G1048, 2005.
145. Hirakata, Y. et al. Adherence to and penetration of human intestinal Caco-2 epithelial cell monolayers by Pseudomonas aeruginosa. Infect. Immun., 66, 1748, 1998.
146. Hunter, P.R. The microbiology of bottled natural mineral waters. J. Appl. Bacteriol., 74, 345, 1993.
147. Warburton, D.W., Bowen, B. and Konkle, A. The survival and recovery of Pseudomonas aeruginosa and its effect upon salmonellae in water: methodology to test bottled water in Canada. Can. J. Microbiol., 40, 987, 1994.
148. Ramalho, R. et al. Modified Pseudomonas agar: new differential medium for the detection/enumeration of Pseudomonas aeruginosa in mineral water. J. Microbiol. Methods, 49, 69, 2002.
149. Goto, S. and Enomoto, S. Nalidixic acid cetrimide agar. A new selective plating medium for the selective isolation of Pseudomonas aeruginosa. Jpn J. Microbiol., 14, 65, 1970.
150. Colquhoun, K.O., Timms, S. and Fricker, C.R. Detection of Escherichia coli in potable water using direct impedance technology. J. Appl. Bacteriol., 79, 635, 1995.
151. Chang, T.C. and Huang, A.H. Rapid differentiation of fermentative from nonfermentative gram-negative bacilli in positive blood cultures by an impedance method. J. Clin. Microbiol., 38, 3589, 2000.
152. Wawerla, M. et al. Impedance microbiology: applications in food hygiene. J. Food Prot., 62, 1488, 1999.
153. Flint, S.H. and Brooks, J.D. Rapid detection of Bacillus stearothermophilus using impedance-splitting. J. Microbiol. Methods, 44, 205, 2001.
154. Cady, P. et al. Impedimetric screening for bacteriuria. J. Clin. Microbiol., 7, 273, 1978.
155. Silverman, M.P. and Munoz, E.F. Automated electrical impedance technique for rapid enumeration of fecal coliforms in effluents from sewage treatment plants. Appl. Environ. Microbiol., 37, 521, 1979.
156. Szita, G. et al. Detection of Pseudomonas aeruginosa in water samples using a novel synthetic medium and impedimetric technology. Lett. Appl. Microbiol., 45, 42, 2007.
157. Szita, G. et al. A novel, selective synthetic acetamide containing culture medium for isolating Pseudomonas aeruginosa from milk. Int. J. Food Microbiol., 43, 123, 1998.
158. Schmidt, S. and Grimes, C.A. Characterization of nanodimensional thin-film elastic moduli using magnetoelastic sensors. Sens. Actuators A Phys., 94, 189, 2001.
159. Zourob, M. et al. A wireless magnetoelastic biosensor for the direct detection of organophosphorus pesticides. Analyst, 132, 338, 2007.
160. Ong, K.G. et al. A rapid highly-sensitive endotoxin detection system. Biosens. Bioelectron., 21, 2270, 2006.
161. Ruan, C. et al. A magnetoelastic bioaffinity-based sensor for avidin. Biosens. Bioelectron., 19, 1695, 2004.
162. Cai, Q. et al. A wireless, remote query glucose biosensor based on a pH-sensitive polymer. Anal. Chem., 76, 4038, 2004.
163. Cai, Q.Y., Jain, M. K. and Grimes, C.A. A wireless, remote query ammonia sensor. Sens. Actuators B Chem., 77, 614, 2001.
164. Cai, Q.Y. and Grimes, C.A. A remote query magnetoelastic pH sensor. Sens. Actuators B Chem., 71, 112, 2000.
165. Cai, Q.Y., Cammers-Goodwin, A. and Grimes, C.A. A wireless, remote query magnetoelastic CO2 sensor. J. Environ. Monit., 2, 556, 2000.
166. Pang, P. et al. Detection of Pseudomonas aeruginosa using a wireless magnetoelastic sensing device. Biosens. Bioelectron., 23, 295, 2007.
167. Sandt, C. et al. FT-IR microspectroscopy for early identification of some clinically relevant pathogens. J. Appl. Microbiol., 101, 785, 2006.
168. Al-Qadiri, H.M. et al. Fourier transform infrared spectroscopy, detection and identification of Escherichia coli O157: H7 and Alicyclobacillus strains in apple juice. Int. J. Food Microbiol., 111, 73, 2006.
169. Wenning, M., Theilmann, V. and Scherer, S. Rapid analysis of two food-borne microbial communities at the species level by Fourier-transform infrared microspectroscopy. Environ. Microbiol., 8, 848, 2006.
170. Jannes, G. and De Vos, D. A review of current and future molecular diagnostic tests for use in the microbiology laboratory. Methods Mol. Biol., 345, 1, 2006.
171. Lin, M.C. et al. Use of oligonucleotide array for identification of six foodborne pathogens and Pseudomonas aeruginosa grown on selective media. J. Food Prot., 68, 2278, 2005.
172. Wang, X.W. et al. Development and application of an oligonucleotide microarray for the detection of food-borne bacterial pathogens. Appl. Microbiol. Biotechnol., 76, 225, 2007.
173. Hong, B.X. et al. Application of oligonucleotide array technology for the rapid detection of pathogenic bacteria of foodborne infections. J. Microbiol. Methods, 58, 403, 2004.
174. Lavenir, R. et al. Improved reliability of Pseudomonas aeruginosa PCR detection by the use of the species-specific ecfX gene target. J. Microbiol. Methods, 70, 20, 2007.
175. Fukushima, H. et al. Rapid separation and concentration of food-borne pathogens in food samples prior to quantification by viable-cell counting and real-time PCR. Appl. Environ. Microbiol., 73, 92, 2007.
176. Lenaerts, J., Lappin-Scott, H.M. and Porter, J. Improved fluorescent in situ hybridization method for detection of bacteria from activated sludge and river water by using DNA molecular beacons and flow cytometry. Appl. Environ. Microbiol., 73, 2020, 2007.
177. Shannon, K.E. et al. Application of real-time quantitative PCR for the detection of selected bacterial pathogens during municipal wastewater treatment. Sci. Total Environ., 382, 121, 2007.
178. Joyanes, P. et al. Evaluation of the VITEK 2 system for the identification and susceptibility testing of three species of nonfermenting gram-negative rods frequently isolated from clinical samples. J. Clin. Microbiol., 39, 3247, 2001.
179. Ling, T.K. et al. Evaluation of VITEK 2 rapid identification and susceptibility testing system against gram-negative clinical isolates. J. Clin. Microbiol., 39, 2964, 2001.
180. Thorpe, T.C. et al. BacT/Alert: an automated colorimetric microbial detection system. J. Clin. Microbiol., 28, 1608, 1990.
181. Chryssanthou, E., Cars, O. and Sjolin, J. New automated method for determining postantifungal effect of amphotericin B against Candida species: effects of concentration, exposure time, and area under the curve. Antimicrob. Agents Chemother., 46, 4016, 2002.
182. Zoetendal, E.G. et al. Isolation of DNA from bacterial samples of the human gastrointestinal tract. Nat. Protoc., 1, 870, 2006.
183. Jaffe, R.I., Lane, J.D. and Bates, C.W. Real-time identification of Pseudomonas aeruginosa direct from clinical samples using a rapid extraction method and polymerase chain reaction (PCR). J. Clin. Lab. Anal., 15, 131, 2001.
184. Nechvatal, J.M. et al. Fecal collection, ambient preservation, and DNA extraction for PCR amplification of bacterial and human markers from human feces. J. Microbiol. Methods, 72, 124, 2008.
185. Flekna, G. et al. Real-time PCR method with statistical analysis to compare the potential of DNA isolation methods to remove PCR inhibitors from samples for diagnostic PCR, Mol. Cell. Probes, 21, 282, 2007.
186. Monteiro, L. et al. Complex polysaccharides as PCR inhibitors in feces: Helicobacter pylori model, J. Clin. Microbiol., 35, 995, 1997.
187. Moissenet, D. et al. [Use of 16S rRNA gene sequencing for identification of “Pseudomonas-like” isolates from sputum of patients with cystic fibrosis], Pathol. Biol. (Paris), 53, 500, 2005.
188. Mah, T.F. and O’Toole, G.A. Mechanisms of biofilm resistance to antimicrobial agents, Trends Microbiol., 9, 34, 2001.
189. Mah, T.F. et al. A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance, Nature, 426, 306, 2003.
190. Zoetendal, E.G. et al. Isolation of RNA from bacterial samples of the human gastrointestinal tract. Nat. Protoc., 1, 954, 2006.
191. Matsuda, K. et al. Sensitive quantitative detection of commensal bacteria by rRNA-targeted reverse transcription-PCR. Appl. Environ. Microbiol., 73, 32, 2007.